Caption Management’s AstraZeneca AZN Stock Holding History

Caption Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4M	Hold	60,000	–	–	0.05%	364
2026 Q1	$11.8M	Buy	60,000 +30,000	+100%	+$5.78M	0.07%	294
2025 Q4	$5.52M	Buy	+30,000	New	+$5.26M	0.04%	489
2023 Q4	–	Sell	-70,000	Closed	-$9.48M	–	1333
2023 Q3	$9.48M	Sell	70,000 -124,450	-64%	-$17M	0.15%	167
2023 Q2	$27.8M	Buy	194,450 +74,450	+62%	+$11M	0.49%	31
2023 Q1	$16.7M	Sell	120,000 -25,000	-17%	-$3.36M	0.32%	70
2022 Q4	$19.7M	Hold	145,000	–	–	0.31%	67
2022 Q3	$15.9M	Buy	145,000 +97,500	+205%	+$12.4M	0.22%	90
2022 Q2	$6.28M	Buy	47,500 +45,000	+1,800%	+$5.9M	0.09%	284
2022 Q1	$331K	Sell	2,500 -172,500	-99%	-$20.7M	﹤0.01%	1202
2021 Q4	$20.4M	Buy	175,000 +100,000	+133%	+$11.8M	0.23%	91
2021 Q3	$9.01M	Hold	75,000	–	–	0.1%	257
2021 Q2	$8.99M	Sell	75,000 -1,550	-2%	-$170K	0.12%	221
2021 Q1	$7.61M	Buy	76,550 +50,000	+188%	+$5.03M	0.16%	158
2020 Q4	$2.65M	Buy	+26,550	New	+$2.81M	0.06%	370
2020 Q3	–	Sell	-25,000	Closed	-$2.64M	–	1032
2020 Q2	$2.64M	Buy	+25,000	New	+$2.58M	0.09%	311

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caption Management's AZN Position: Q2 2026 in Review

Caption Management opened a new position in AstraZeneca (AZN) in Q2 2026: 34,800 shares worth $6.6M. The stake represents 0.03% of the portfolio and ranks #510 among its holdings. This is a return to the name: Caption Management previously reported a position in AZN as recently as Q4 2025.

Caption Management first reported a position in AZN in Q2 2020 and has held it in 18 quarters since. The position peaked at $16.4M in Q4 2025. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Caption Management held 34,800 shares of AstraZeneca worth $6.6M as of Q2 2026.
AstraZeneca was a new Caption Management position in Q2 2026.
AstraZeneca made up 0.03% of Caption Management's portfolio in Q2 2026, its #510 holding.
Caption Management first reported a position in AstraZeneca in Q2 2020 and has held it in 18 quarters since.
Caption Management's AstraZeneca position peaked at $16.4M in Q4 2025.
1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.